Year 2020 Vol. 28 No 3

TRANSPLANTOLOGY

A.V. VATAZIN, A.B. ZULKARNAEV, V.A. STEPANOV

A PERSPECTIVE APPROACH TO THE TISSUE COMPATIBILITY ASSESSMENT OF A DONOR AND A RECIPIENT DURING CADAVERIC KIDNEY TRANSPLANTATION

Moscow Regional Research Clinical Institute named after M.F. Vladimirskiy, Moscow,
The Russian Federation

Objective. To perform a multiple factor analysis of the impact of the epitope mismatche number on the renal transplant survival.
Methods. An observational retrospective cohort study including 824 adult kidney graft recipients was performed.
Results. All recipient donor pairs had human leukocyte antigen mismatches. Significant risk factors for graft loss in the preassigned multivariate model were as follows: HLA MM (1 – HR 1; 2– HR 1.24 [95% confidence interval – 95% CI 0.7; 2.15], p=0.344; 3 – HR 1 , 48 [95% CI 0.86; 2.33], p=0.251; 4 – HR 1.88 [95% CI 1.32; 2.52], p<0.001; 5 – HR 2.41 [95 % CI 2; 2.93], p<0.001; 6 – HR 2.98 [95% CI 2.59; 3.46], p<0.001) p<0.001; duration of HR conservation 1.08 per hour [95% CI 1.02; 1.16], p=0.01; panel-reactive antibodies value (PRA) HR 1.24 per every 10% [95% CI 1.06; 1.58], p=0.01; but not the type of donor, age and gender of the recipient.
When including the epitope mismatches (EpMM) in the model, significant risk factors were: EpMM (<10– HR 1; 10-19– HR 1.71 [95% CI 1.09; 2.49], p=0.021; 20-29 – HR 2,11 [95% CI 1.59; 2.68], p<0.001; 30-39 – HR 2.4 [95% CI 1.96; 2.86], p<0.001; 40-49 – HR 2 , 59 [95% CI 2.17; 3.04], p<0.001; ≥50 – HR 2.71 [95% CI 2.31; 3.15], p<0.001) p<0.001; PRA HR 1.18 for every 10% [95% CI 1.09; 1.5], p=0.007; but not the duration of conservation, donor type, age and gender of the recipient. However, HLA MM was no longer a significant risk factor for HR graft loss 1.19 [95% CI 0.88; 1.55], p=0.451
Conclusions. The number of epitope mismatches between donor phenotype and recipient phenotype remains an important factor in long-term graft survival, even in despite of some corrections of the number of HLA mismatches, the donor type and the level of pre-sensitization of the recipient.

Keywords: kidney transplantation, HLA, epitope, eplet, tissue compatibility, recipient selection
p. 268-275 of the original issue
References
  1. Williams RC, Opelz G, Weil EJ, McGarvey CJ, Chakkera HA. The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts 2: Living Donors, Summary, Guide. Transplantation Direct. 2017 May;3(5):e152. doi: 10.1097/TXD.0000000000000664
  2. Posmertnoe donorstvo organov. Natsional’nye klinicheskie rekomendatsii [Elektronnyi resurs]. Ros transplantol o-vo; 2016 [data dostupa 2019 Avg 20]. 59 p. Rezhim dostupa: http://transpl.ru/files/rto/possmertnoe_dnorstvo_organov.pdf (In Russ.)
  3. Abramowicz D, Cochat P, Claas FH, Heemann U, Pascual J, Dudley C, Harden P, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squifflet JP, Steiger J, Torres A, Viklicky O, Zeier M, Vanholder R, Van Biesen W, Nagler E. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant. 2015 Nov;30(11):1790-97. doi: 10.1093/ndt/gfu216
  4. Shi X, Lv J, Han W, Zhong X, Xie X, Su B, Ding J. What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients. BMC Nephrol. 2018 May 18;19(1):116. doi: 10.1186/s12882-018-0908-3
  5. Massie AB, Leanza J, Fahmy LM, Chow EK, Desai NM, Luo X, King EA, Bowring MG, Segev DL. A risk index for living donor kidney transplantation. Am J Transplant. 2016 Jul;16(7):2077-84. doi: 10.1111/ajt.13709
  6. Campos A, Malheiro J, Tafulo S, Santos S, Dias L, Martins S, Almeida M, Pedroso S, Henriques AC, Cabrita A. Increase of allosensitization after a kidney graft failure: Predictors and effect on retransplantation outcomes. Nefrologia. 2017 Jul-Aug;37(4):397-405. doi: 10.1016/j.nefro.2016.11.020 [Article in English, Spanish]
  7. Lim WH, Chadban SJ, Clayton P, Budgeon CA, Murray K, Campbell SB, Cohney S, Russ GR, McDonald SP. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clin Transplant. 2012 Jul-Aug;26(4):E428-37. doi: 10.1111/j.1399-0012.2012.01654.x
  8. Süsal C, Opelz G. Current role of human leukocyte antigen matching in kidney transplantation. Curr Opin Organ Transplant. 2013 Aug;18(4):438-44. doi: 10.1097/MOT.0b013e3283636ddf
  9. Snell GD, Dausset J, Nathanson S. Histocompatibility. New York: Academic Press; 1976. 401 p.
  10. The National Marrow Donor Program Database [Internet] [cited 2018 May 12]. Available from: https://bioinformatics.bethematchclinical.org/
  11. The Allele Frequency Net Database [Internet] [cited 2018 May 12]. Available from: http://www.allelefrequencies.net
  12. HLA Epitope Registry Database [Internet] [cited 2018 May 12]. Available from: https://www.epregistry.com.br/
  13. Stolyarevich ES, Zhilinskaya TR, Artyukhina LYu, Kim IG, Zaydenov VA, Tomilina NA. Morphological structure of late renal graft dysfunction and its effect for long-term results. Russian Journal of Transplantology and Artificial Organs. 2018;20(1):45-54. doi: 10.15825/1995-1191-2018-1-45-54 (In Russ.)
  14. Campos A, Malheiro J, Tafulo S, Santos S, Dias L, Martins S, Almeida M, Pedroso S, Henriques AC, Cabrita A. Increase of allosensitization after a kidney graft failure: Predictors and effect on retransplantation outcomes. Nefrologia. 2017 Jul-Aug;37(4):397-405. doi: 10.1016/j.nefro.2016.11.020 [Article in English, Spanish]
  15. Jerne NK. Immunological speculations. Annu Rev Microbiol. 1960;14:341-58. doi: 10.1146/annurev.mi.14.100160.002013
  16. Lobashevsky AL, Senkbeil RW, Shoaf JL, Stephenson AK, Skelton SB, Burke RM, Deierhoi MH, Thomas JM. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Hum Immunol. 2002 May;63(5):364-74. doi: 10.1016/s0198-8859(02)00371-3
  17. Dankers MK, Witvliet MD, Roelen DL, de Lange P, Korfage N, Persijn GG, Duquesnoy R, Doxiadis II, Claas FH. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation. 2004 Apr 27;77(8):1236-39. doi: 10.1097/01.tp.0000120385.03278.28
  18. Duquesnoy RJ, Takemoto S, de Lange P, Doxiadis II, Schreuder GM, Persijn GG, Claas FH. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation. 2003 Mar 27;75(6):884-89. doi: 10.1097/01.TP.0000055101.20821.AC
Address for correspondence:
129110, Russian Federation,
Moscow, Schepkin str., 61/2, 6,
Moscow Regional Research Clinical Institute
Named after M.F. Vladimirskiy,
the Surgical Department of Kidney Transplantation,
tel. mobile +7-916-705-98-99,
e-mail:7059899@gmail.com,
Zulkarnaev Alexey B.
Information about the authors:
Vatazin Andrey V., MD, Professor, Chief Researcher of the Surgical Department of Kidney Transplantation, Moscow Regional Research Clinical Institute Named after M.F. Vladimirskiy, Moscow, the Russian Federation.
http://orcid.org/0000-0001-8497-0693
Zulkarnaev Alexey B., MD, Associate Professor, Leading Researcher of the Surgical Department of Kidney Transplantation, Moscow Regional Research Clinical Institute Named after M.F. Vladimirskiy, Moscow, Russian Federation.
http://orcid.org/0000-0001-5405-7887
Stepanov Vadim A., PhD, Senior Researcher of the Surgical Department of Kidney Transplantation, Moscow Regional Research Clinical Institute Named after M.F. Vladimirskiy, Moscow, Russian Federation.
http://orcid.org/0000-0002-0881-0599
Contacts | ©Vitebsk State Medical University, 2007-2023